Showing results (191-200 of 353) with videos related to
Sort By:
Pageof 36
Therapeutic Drug Monitoring|October 1, 1993
Development and validation of a limited sampling strategy for 5-fluorouracil given by bolus intravenous administrationM J Moore, P Bunting, S Yuan, et al.British Journal of Cancer|February 13, 2001
Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein functionT Muzzammil, M J Moore, D Hedley, et al.The EMBO Journal|September 5, 2001
The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decayH Le Hir, D Gatfield, E Izaurralde, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 10, 1999
Prostate cancer: 9. Treatment of advanced diseaseM E Gleave, N Bruchovsky, M J Moore, et al.Current Oncology (Toronto, Ont.)|February 14, 2014
Cost-effectiveness of folfirinox for first-line treatment of metastatic pancreatic cancerC L Attard, S Brown, K Alloul, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Domain structure of the glucocorticoid receptor proteinJ Carlstedt-Duke, P E Strömstedt, O Wrange, et al.Therapeutic Drug Monitoring|June 1, 1987
Analysis of phosphoramide mustard by reversed-phase ion pair high pressure liquid chromatographyR W Hardy, M J Moore, C Erlichman, et al.Journal of Health Economics|May 27, 1999
The effects of short-term variation in abortion funding on pregnancy outcomesP J Cook, A M Parnell, M J Moore, et al.British Journal of Urology|October 17, 1998
Adjuvant chemotherapy for high-risk urothelial transitional cell carcinoma: the Princess Margaret Hospital experienceM Michael, I F Tannock, P M Czaykowski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
Pharmacological determinants of 9-aminocamptothecin cytotoxicityM L Li, L Horn, P S Firby, et al.Pageof 36